Value HR Co.,Ltd.
6078・Prime Market・Services
Business
Value HR Co., Ltd. was established in 2001. Centered on its in-house developed health management platform "Value Cafeteria® System," the company digitizes health information and provides health management services targeting health insurance societies, corporations, and individuals. Its main businesses consist of two segments: the Value Cafeteria Business (health management services including outsourced administrative work such as health checkup reservations, results management, and specific health guidance) and the HR Management Business (consulting and BPO support for the establishment of new health insurance societies). The company is listed on the Prime Market of the Tokyo Stock Exchange. It operates as a group comprising four consolidated subsidiaries (Value Networks, Value Healthcare, Value HR Ventures, and Kenshin Yoyaku.com) as well as Online Doctor Co., Ltd.
Business Model
The main revenue sources are system usage fees for the Value Cafeteria® System, charged according to the number of members in each contracted organization, and administrative agency fees for services such as health checkup expense settlement and results data conversion. In the HR Management Business, the company earns consulting fees and BPO service fees. By providing an integrated service from health insurance society establishment support through to operational BPO, the company has built a recurring structure that secures continued orders after establishment. Partner sales through business alliances with Hoken Kenkyujo, Daido Life, Tokio Marine & Nichido, and others complement the customer acquisition channels.
Company Strengths
Since its founding in 2001, the company has developed and continuously expanded in-house the "Value Cafeteria® System," an integrated platform combining health checkup scheduling, results management, metabolic syndrome countermeasures, medical expense statements, and stress checks. This unified system, which accumulates individual health data linked to user IDs, generates competitive advantage through the accumulation of information from continued usage.
The company has concluded business alliance agreements with more than 10 companies, including Hoken, Amano Soken, Reloclub, Daido Life, Tokio Marine & Nichido, Daiwa Institute of Research, Mental Health Technologies, and Nippon Life. Through partner sales combining OEM provision, sales agency arrangements, and system integration, it has built a multi-layered customer acquisition channel that supplements its own sales force.
The company has been selected multiple times as a Health & Productivity Management Stock, in 2021, 2022, 2023, 2025, and 2026, and has continuously obtained certification as an Excellent Health & Productivity Management Corporation (White 500) from 2017 through 2026. The fact that the company itself practices health and productivity management serves as a track record underpinning the credibility and appeal of its health management support services.
ENVALITH's Perspective
Performance Trend
Revenue achieved five consecutive years of growth, rising from ¥5,526 million in FY2021 to ¥10,068 million in FY2025. In Q1 FY2026 (ending December 2026), revenue also maintained its growth trend at ¥2,557 million (up 12.6% year on year). Meanwhile, operating profit peaked at ¥1,386 million in FY2023, then declined for two consecutive periods to ¥1,118 million in FY2024 and ¥883 million in FY2025. Q1 FY2026 (ending December 2026) also saw continued profit decline at ¥195 million (down 21.5% year on year). The main cause was an increase in personnel expenses associated with strengthened hiring in the latter half of the previous period, with cost of sales rising to ¥1,847 million (up 20.6% year on year), an increase exceeding the growth in revenue. Comprehensive income deteriorated significantly to ¥56 million (down 65.0% year on year), also affected by a decrease in valuation difference on available-for-sale securities (down ¥74 million). The full-year forecast (revenue of ¥11,000 million, operating profit of ¥1,650 million) remains unchanged, premised on a recovery in profitability in the latter half of the period.
Growth Strategy
With the dual pillars of building an in-house operations foundation and expanding the customer base, the company aims to renew its record-high operating profit in FY2026 (ending December 2026)
The company is promoting in-house operations by leveraging personnel increased through stronger hiring in the latter half of the previous fiscal year, thereby reducing reliance on outsourcing such as staffing and outsourced services. In Q1 FY2026 (ending December 2026), progress was made in efforts to reduce outsourcing costs, and management explains that the cost structure is transitioning into a normalization phase.
The company is accelerating new customer development by continuing to hold web seminars on the theme of health management, both self-hosted and co-hosted with partners, and by expanding its sales network with collaborating partners. In Q1 FY2026 (ending December 2026), new customer acquisition increased steadily, and growth in the number of users was confirmed.
The company continues to expand orders for consulting and BPO services aimed at health insurance societies. In Q1 FY2026 (ending December 2026), operating profit for this business reached ¥91 million (+72.8% year on year), a significant increase, and its contribution to profitability is growing.
On April 13, 2026, the company granted the 24th series of stock acquisition rights (covering 426,900 shares, exercise price of ¥1,586 per share, exercise period from April 13, 2026 to April 13, 2036) to 8 directors. The aim is to strengthen commitment to increasing corporate value and improving business performance over the medium to long term.
Last updated: July 17, 2026